Publication Author: Abernethy_Neil

• Large benefits to youth-focused HIV treatment-as-prevention efforts in generalized heterosexual populations: An agent-based simulation model.

  Mittler JE, Murphy JT, Stansfield SE, Peebles K, Gottlieb GS, Abernethy NF, Reid MC, Goodreau SM, Herbeck JT. Large benefits to youth-focused HIV treatment-as-prevention efforts in generalized heterosexual populations: An agent-based simulation model. PLo

  rakerr2

  December 1, 2019

• Models to predict the public health impact of vaccine resistance: A systematic review.

  Reid MC, Peebles K, Stansfield SE, Goodreau SM, Abernethy N, Gottlieb GS, Mittler JE, Herbeck JT. Models to predict the public health impact of vaccine resistance: A systematic review. Vaccine. 2019 Aug 14;37(35):4886-4895. doi: 10.1016/j.vaccine.2019.07.

  rakerr2

  August 14, 2019

• Relational concurrency, stages of infection, and the evolution of HIV set point viral load.

  Goodreau SM, Stansfield SE, Murphy JT, Peebles KC, Gottlieb GS, Abernethy NF, Herbeck JT, Mittler JE. Relational concurrency, stages of infection, and the evolution of HIV set point viral load. Virus Evol. 2018 Nov 21;4(2):vey032. doi: 10.1093/ve/vey032.

  rakerr2

  July 1, 2018

• HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.

  Herbeck JT, Peebles K, Edlefsen PT, Rolland M, Murphy JT, Gottlieb GS, Abernethy N, Mullins JI, Mittler JE, Goodreau SM. HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine. Vaccine. 2018 Jan 25;36(4):514-520.

  rakerr2

  December 11, 2017

• Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians.

  Overby CL, Devine EB, Abernethy N, McCune JS, Tarczy-Hornoch P. Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians. J Biomed Inform. 2015 Jun;55:249-59. doi: 10.1016/j.jbi.2015.04.011. Epub 2015 Ma

  rakerr2

  June 1, 2015

• Visualization and analytics tools for infectious disease epidemiology: a systematic review.

  Carroll LN, Au AP, Detwiler LT, Fu TC, Painter IS, Abernethy NF. Visualization and analytics tools for infectious disease epidemiology: A systematic review. J Biomed Inform. 2014 Oct;51C:287-298. doi: 10.1016/j.jbi.2014.04.006. Epub 2014 Apr 16. Review.

  rakerr2

  October 1, 2014

• Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: a mixed methods approach.

  Devine EB, Lee CJ, Overby CL, Abernethy N, McCune J, Smith JW, Tarczy-Hornoch P. Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: a mixed methods approa

  rakerr2

  July 1, 2014

• Expanding assessments of translational research programs: supplementing metrics with value judgments.

  Scott CS, Nagasawa PR, Abernethy NF, Ramsey BW, Martin PJ, Hacker BM, Schwartz HD, Brock DM, Robins LS, Wolf FM, Carter-Dubois M, Disis ML. Expanding assessments of translational research programs: supplementing metrics with value judgments. Eval Health P

  rakerr2

  March 1, 2014

• Using random walks to identify cancer-associated modules in expression data.

  Petrochilos D, Shojaie A, Gennari J, Abernethy N. Using random walks to identify cancer-associated modules in expression data. BioData Min. 2013 Oct 15;6(1):17. doi: 10.1186/1756-0381-6-17.

  rakerr2

  October 15, 2013

• Key findings and lessons from an evaluation of the Rockefeller Foundation’s Disease Surveillance Networks Initiative.

  Macpherson N, Kimball AM, Burke C, Abernethy N, Tempongko S, Zinsstag J. Key findings and lessons from an evaluation of the Rockefeller Foundation’s Disease Surveillance Networks Initiative. Emerg Health Threats J. 2013;6. doi: 10.3402/ehtj.v6i0.19959. Ep

  rakerr2

  January 25, 2013